Educational videos for people newly diagnosed with sarcoma
Evaluating the Use of Educational Videos in a Medical Oncology Sarcoma Clinic to Improve Patient Knowledge and Satisfaction.
This project will test whether watching four short sarcoma-specific videos before the first oncology visit helps newly diagnosed adults (or their caregivers) better understand the disease and treatment options.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Mount Sinai Hospital, Canada Academic / other |
| Locations | 1 site (Toronto, Ontario) |
| Trial ID | NCT06805773 on ClinicalTrials.gov |
What this trial studies
Adults with newly diagnosed advanced or metastatic sarcoma (or their caregivers) will watch four targeted educational videos before their first appointment with a medical oncologist. Participants will complete questionnaires measuring their knowledge and understanding before the videos and again after the first clinic visit. The intervention is compared with standard of care education provided in the clinic. The setting is Mount Sinai Hospital in Toronto and enrollment requires informed consent and English literacy.
Who should consider this trial
Good fit: Adults (≥18) with histologically confirmed advanced/metastatic sarcoma who have not received prior systemic treatment, or their caregivers, who can read and write English and provide informed consent.
Not a fit: People who have already been seen by a medical oncologist for their sarcoma, those with previous systemic sarcoma treatment, those unable to consent, or those who cannot read English are not likely to benefit from this intervention.
Why it matters
Potential benefit: If successful, patients may come into their first oncology visit better informed and more prepared to discuss treatment choices, improving communication and decision-making.
How similar studies have performed: Educational video interventions in other cancer settings have often improved patient knowledge and preparedness, though using this approach specifically for sarcoma is relatively uncommon.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Signed written and voluntary informed consent. 2. Have histologically documented advanced metastatic sarcoma, or is a caregiver of a patient with histologically documented advanced metastatic sarcoma. 3. Age ≥ 18 years. 4. Have not received any previous systemic treatment for sarcoma, or is a caregiver of a sarcoma patient who has not received any previous systemic treatment for sarcoma. 5. Willing/able to complete questionnaires. 6. Able to read and write in English. Exclusion Criteria: 1. Inability to provide informed consent. 2. Previously seen by a medical oncologist for their sarcoma.
Where this trial is running
Toronto, Ontario
- Mount Sinai Hospital — Toronto, Ontario, Canada (Recruiting)
Study contacts
- Study coordinator: Clinical Trials Manager
- Email: Oncology.Research@sinaihealth.ca
- Phone: 416-586-8440
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.